GLP-1 medications saw significant improvements across a staggering range of health concerns beyond weight reducing or blood sugar. The patients experienced improvements in addiction and psychotic disorders and the risk of Alzheimer's was decreased.
GLP-1RA drugs act on receptors that are expressed in brain areas involved in impulse control, reward, and addiction, which may potentially explain their effectiveness in curbing appetite and addiction disorders.
Aging
GLP-1 is economic earthquake since it affects every type of consumption